We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu
IMPORTANT: Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

The Related Factors With Resilience in Caregivers Whose Child With Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01249781
Recruitment Status : Unknown
Verified November 2010 by China Medical University Hospital.
Recruitment status was:  Enrolling by invitation
First Posted : November 30, 2010
Last Update Posted : November 30, 2010
Information provided by:

Study Description
Brief Summary:
The purpose of this study was to explore caregivers stress, family functioning, social support and family resilience of families whose children had acute lymphoblastic leukemia. The significantly correlation among caregivers stress, family functioning, social support and family resilience was also explored.

Condition or disease
Condition 1. Children With ALL Are Still Alive and the Age of 18 Years of Age. Condition 2. Has Been Completed to Guide the Treatment Regimen Were in Remission. Condition 3. Caregiver Can or Taiwanese Language Communicator.

Study Design

Study Type : Observational
Estimated Enrollment : 50 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Study Start Date : September 2010

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Caregivers
U.S. FDA Resources

Groups and Cohorts

resilience in caregivers whose child with ALL

Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   up to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Families of children was diagnosed acute lymphoblastic leukemia

Inclusion Criteria:

  1. Diagnosed as acute lymphoblastic leukemia children, children with cancer are still alive and the age of 18 years of age.
  2. Has been completed to guide the treatment regimen were in remission.
  3. Caregiver can or Taiwanese language communicator.

Exclusion Criteria:

- Children with metastatic cancer who end chemical treatment of more than one year

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01249781

China Medical University Hospital
Taichung, No.2 Yuh Der Road, Taiwan
Sponsors and Collaborators
China Medical University Hospital
More Information

Responsible Party: China Medical University Hospital, China Medical University
ClinicalTrials.gov Identifier: NCT01249781     History of Changes
Other Study ID Numbers: DMR-99-IRB-191
First Posted: November 30, 2010    Key Record Dates
Last Update Posted: November 30, 2010
Last Verified: November 2010

Additional relevant MeSH terms:
Pathologic Processes